BUDGET IMPACT ANALYSIS OF INHIBITOR HAEMOPHILIA A THERAPY WITH BYPASSING AGENTS
The aim of this study is to analyse the budget impact of hemophilia A therapy with either APCC or rFVIIa, in case of persistent inhibitors development. The point of view is that of the Bulgarian health care system for a one-year period. A budget impact analysis (BIA) was performed following the rec...
| Main Authors: | , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Peytchinski Publishing
2019-04-01
|
| Series: | Journal of IMAB |
| Subjects: |